AIM: To investigate the association between Helicobacter pylori (H. pylori) infection and the prevalence of Crohn's disease (CD). METHODS: Subjects were selected from patients admitted the gastrointestinal (GI) department at The First Affiliated Hospital School of Medicine (Zhejiang University) for abdominal pain, hematochezia, diarrhea and other GI symptoms between January 2008 and September 2012. CD was diagnosed by endoscopy and biopsy. H. pylori infection was detected by a (14)C-urea breath test and culturing of the biopsy sample. Demographic, anthropometric and serologic data were collected for each patient. H. pylori infection rate was compared between CD and control groups, followed by a subgroup analysis based on extent and severity of CD. Student's t, Mann-Whiney U, and χ(2) tests were used to analyze the data. RESULTS: A total of 447 patients were analyzed, including 229 in the CD group and 248 in the control group. There were no significant differences in age, sex, and rates of hypertension or diabetes. However, the CD group showed significantly higher rates of smoking history (34.9% vs 18.1%), alcohol intake (17.4% vs 8.1%), white blood cell count (9.7 ± 2.9 × 10(9)/L vs 4.3 ± 0.9 × 10(9)/L), and C-reactive protein (36.3 ± 20.8 mg/L vs 5.5 ± 2.3 mg/L) but lower body mass index (24.5 ± 2.0 kg/m(2) vs 26.0 ± 2.2 kg/m(2)) than the control group. The H. pylori infection rate in the CD group was 27.1%, significantly lower than that of 47.9% in the control group. Furthermore, the H. pylori infection rates in patients with colonic, small intestine, ileocolonic and extensive CD were 31.1%, 28.9%, 26.8% and 25.9% respectively, all of which were significantly lower than in the control group. Finally, the H. pylori infection rates in patients with remission, moderate and severe CD were 34.3%, 30.7% and 22.0% respectively, which were also significantly lower than in the control group. CONCLUSION: Lower H. pylori infection in CD patients suggests a correlation between bacterial infection and CD, suggesting caution when considering H. pylori eradication in CD patients.
AIM: To investigate the association between Helicobacter pylori (H. pylori) infection and the prevalence of Crohn's disease (CD). METHODS: Subjects were selected from patients admitted the gastrointestinal (GI) department at The First Affiliated Hospital School of Medicine (Zhejiang University) for abdominal pain, hematochezia, diarrhea and other GI symptoms between January 2008 and September 2012. CD was diagnosed by endoscopy and biopsy. H. pyloriinfection was detected by a (14)C-urea breath test and culturing of the biopsy sample. Demographic, anthropometric and serologic data were collected for each patient. H. pyloriinfection rate was compared between CD and control groups, followed by a subgroup analysis based on extent and severity of CD. Student's t, Mann-Whiney U, and χ(2) tests were used to analyze the data. RESULTS: A total of 447 patients were analyzed, including 229 in the CD group and 248 in the control group. There were no significant differences in age, sex, and rates of hypertension or diabetes. However, the CD group showed significantly higher rates of smoking history (34.9% vs 18.1%), alcohol intake (17.4% vs 8.1%), white blood cell count (9.7 ± 2.9 × 10(9)/L vs 4.3 ± 0.9 × 10(9)/L), and C-reactive protein (36.3 ± 20.8 mg/L vs 5.5 ± 2.3 mg/L) but lower body mass index (24.5 ± 2.0 kg/m(2) vs 26.0 ± 2.2 kg/m(2)) than the control group. The H. pyloriinfection rate in the CD group was 27.1%, significantly lower than that of 47.9% in the control group. Furthermore, the H. pyloriinfection rates in patients with colonic, small intestine, ileocolonic and extensive CD were 31.1%, 28.9%, 26.8% and 25.9% respectively, all of which were significantly lower than in the control group. Finally, the H. pyloriinfection rates in patients with remission, moderate and severe CD were 34.3%, 30.7% and 22.0% respectively, which were also significantly lower than in the control group. CONCLUSION: Lower H. pyloriinfection in CD patients suggests a correlation between bacterial infection and CD, suggesting caution when considering H. pylori eradication in CD patients.
Authors: Daniel C Baumgart; Charles N Bernstein; Zaigham Abbas; Jean F Colombel; Andrew S Day; Geert D'Haens; Iris Dotan; Khean L Goh; Toshifumi Hibi; Richard A Kozarek; Eamonn M M Quigley; Walter Reinisch; Bruce E Sands; Jose D Sollano; A Hillary Steinhart; Flávio Steinwurz; Morten H Vatn; Jesús K Yamamoto-Furusho Journal: Inflamm Bowel Dis Date: 2011-02 Impact factor: 5.325
Authors: I Surveyor; C S Goodwin; B P Mullan; E Geelhoed; J R Warren; R N Murray; T E Waters; C R Sanderson Journal: Med J Aust Date: 1989-10-16 Impact factor: 7.738
Authors: Bodo Linz; François Balloux; Yoshan Moodley; Andrea Manica; Hua Liu; Philippe Roumagnac; Daniel Falush; Christiana Stamer; Franck Prugnolle; Schalk W van der Merwe; Yoshio Yamaoka; David Y Graham; Emilio Perez-Trallero; Torkel Wadstrom; Sebastian Suerbaum; Mark Achtman Journal: Nature Date: 2007-02-07 Impact factor: 49.962
Authors: Lars E Bartels; Peter Jepsen; Lisbet A Christensen; Lars U Gerdes; Hendrik Vilstrup; Jens F Dahlerup Journal: J Crohns Colitis Date: 2015-12-16 Impact factor: 9.071
Authors: Christiane Barthel; Sandra Wiegand; Sylvie Scharl; Michael Scharl; Pascal Frei; Stephan R Vavricka; Michael Fried; Michael Christian Sulz; Nico Wiegand; Gerhard Rogler; Luc Biedermann Journal: Nutr J Date: 2015-08-12 Impact factor: 3.271